LMAT Director John O'Connor Receives 4.744 Shares via Awards

What Happened John James O'Connor, a director of Lemaitre Vascular, received a total of 4.744 dividend-equivalent shares (fractional share amounts: 0.543, 0.65, 0.885, 1.002, 1.664) on 2026-09-03 as awards (derivative transactions). Each was recorded at $0.00 per share (no cash paid). These amounts represent dividend equivalents that accrued on previously granted restricted stock units (RSUs) and performance share units (PSUs) and vest proportionately with those awards—this is a compensation/award event, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-03; Filing date: 2026-09-08 (filed 5 days after the transaction; appears delayed vs. the typical 2-business-day Form 4 requirement).
• Price: $0.00 per share (dividend-equivalent rights credited, not purchased).
• Shares received: 0.543, 0.65, 0.885, 1.002, 1.664 (total = 4.744 shares).
• Nature: Recorded as derivative awards (code A); each dividend-equivalent right is the economic equivalent of one share.
• Footnotes: F1–F5 indicate these dividend equivalents accrued on RSU/PSU awards granted on 12/8/2023, 12/6/2024, and 12/10/2025 and vest proportionately with those awards.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.

Context Dividend-equivalent rights accrue additional value tied to RSUs/PSUs and typically convert to shares or cash when the underlying awards vest; they are a form of compensation rather than a market buy or sell. Such awards are routine for insiders and do not, by themselves, signal a buy/sell market view. The slightly delayed filing may be worth noting for compliance review but does not change the economic nature of the transaction.